Capital Flow Monitor · Sponsors · CIK 1989669
BlueWhale Bio, Inc.
2929 ARCH ST, PHILADELPHIA, PA, 19104 · 617-595-7783
Biotechnology · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$15.0M
Sold
$5.0M
% sold
33.3%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-16 | D ·current | 506(b) | $15.0M | $5.0M | 33.3% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Peter Keller — Executive Officer / Director, Philadelphia, PA
- Paula Cannon — Director, Philadelphia, PA
-
Elaine Heron — Director, Philadelphia, PA
1 other raise
- Enumera Molecular, Inc. $12.3M of $17.4M · 70.9%
-
Paul Meister — Director, Philadelphia, PA
5 other raises
- Way Biosolutions, Inc. $2.0M of $2.0M · 100.0%
- Everest Biolabs, Inc. $4.4M of $5.7M · 77.0%
- GCM Grosvenor Credit Secondaries Structured Note 2025, L.P. $625.0M of —
- GCM Grosvenor Credit Secondaries Structured Note 2025 Feeder, L.P. $10.4M of —
- Flywheel Exchange Inc. $16.4M of $27.4M · 59.7%
- Beate Mueller-Tiemann — Director, Philadelphia, PA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.